发明名称 Mmp-2 propeptide for use as antiangiogenic or antitumor agent
摘要 Methods and compositions for inhibiting growth of a tumor, inhibiting angiogenesis and inhibiting extracellular matrix destruction in a mammal are disclosed. The method includes administering a therapeutically effective amount of a polypeptide that contains the sequence ProArgCysGlyXaaProAsp, wherein Xaa represents Val or Asn (SEQ ID NO:6). Preferably, the polypeptide is 60 to 100 amino acids in length. In some embodiments, the polypeptide is a human MMP-2 propeptide (SEQ ID NO:1) or an MMP-2 propeptide-like polypeptide, i.e., a polypeptide having at least 80% sequence identity with SEQ ID NO:1.
申请公布号 AU5586101(A) 申请公布日期 2001.11.07
申请号 AU20010055861 申请日期 2001.04.19
申请人 THE GENERAL HOSPITAL CORPORATION 发明人 LAWRENCE WEISSBACH
分类号 A61K38/48;A61P43/00 主分类号 A61K38/48
代理机构 代理人
主权项
地址